Sandra Navarra

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Brad H. Rovin, Y K Onno Teng, Ellen M. Ginzler et al. · The Lancet · 2021 · 534 citations

Glomerulonephritis, Autoimmune Disease, Voclosporin Versus Placebo +9

A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study

Dae‐Hyun Yoo, Artur Racewicz, Jan Brzezicki et al. · Arthritis Research & Therapy · 2016 · 170 citations · Full text

Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study

Vera Golder, Rangi Kandane‐Rathnayake, Alberta Hoi et al. · Arthritis Research & Therapy · 2017 · 129 citations · Full text

Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus

DJ Wallace, Sandra Navarra, M. Pétri et al. · Lupus · 2012 · 118 citations

Impact of systemic lupus erythematosus on health, family, and work: The patient perspective

Don Robinson, Daniel Aguilar, Melissa Schoenwetter et al. · Arthritis Care & Research · 2010 · 106 citations